SignalEU/UK

Alnylam drops as AstraZeneca posts full trial results for failed heart drug

Trial failure for heart drug triggers selloff, AstraZeneca data confirms setback.

What changed

Trial failure for heart drug triggers selloff, AstraZeneca data confirms setback.

Why it matters

Trial failure for heart drug triggers selloff, AstraZeneca data confirms setback. — impact context not separately stored; see What changed.

Sources